Neurocrine Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 15 Aug 24 | SellUS$2,090,333 | William Rastetter | Individual | 14,250 | US$146.69 |
Insider Trading Volume
Insider Buying: NBIX insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 111,445 | 0.11% |
| Individual Insiders | 1,086,762 | 1.08% |
| General Public | 4,713,170 | 4.67% |
| Institutions | 95,064,872 | 94.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 14,190,708 | US$1.6b | 3.12% | 0.03% | |||
| 10,056,446 | US$1.2b | 1.26% | 0.02% | |||
| 4,608,357 | US$530.2m | 15.5% | 0.02% | |||
| 2,468,146 | US$284.0m | 9.62% | 0.45% | |||
| 2,190,960 | US$252.1m | 6.37% | 0.03% | |||
| 1,898,640 | US$218.5m | -7.65% | 2.48% | |||
| 1,819,622 | US$209.4m | 6.18% | 0.02% | |||
| 1,798,848 | US$207.0m | -1.21% | 0.02% | |||
| 1,280,820 | US$147.4m | 1.23% | 0.05% | |||
| 1,228,991 | US$141.4m | 47.2% | 0.01% | |||
| 1,141,385 | US$131.3m | 19.2% | 0.19% | |||
| 1,074,237 | US$123.6m | -13.9% | 0.03% | |||
| 1,064,473 | US$122.5m | 37.7% | 0.03% | |||
| 997,784 | US$114.8m | -12.2% | 1.66% | |||
| 994,888 | US$114.5m | -8.59% | 0.14% | |||
| 978,488 | US$112.6m | -4.42% | 2.77% | |||
| 971,203 | US$111.7m | -29.6% | 0.04% | |||
| 940,000 | US$108.2m | -10.9% | 3.18% | |||
| 917,806 | US$105.6m | 1.37% | 0.02% | |||
| 899,493 | US$103.5m | -10.4% | 0.02% | |||
| 871,324 | US$100.3m | -19.4% | 0.07% | |||
| 810,620 | US$93.3m | 13.4% | 0.01% | |||
| 783,291 | US$90.1m | 25.6% | 0.02% | |||
| 782,870 | US$90.1m | -0.93% | 0.13% | |||
| 781,529 | US$89.9m | 2.28% | 0.03% |